StockData
Vireo Growth Inc. logo

Vireo Growth Inc. (VREOF) stock

VREOFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/30
$9.01+0.01 (+0.11%)

Close on Oct 19, 2026Market cap $443.48MP/E –Yield –

Vireo Growth operating margin

Operating margin is operating income as a percentage of revenue.

Vireo Growth's operating margin for the twelve months ending Sep 30, 2026 was 1.3%. For fiscal 2025 it was -0.4%, against 13.6% the year before. The highest annual figure on record is 13.6% in fiscal 2024.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-0.4%−14.0
FY2024Dec 31, 202413.6%+1.6
FY2023Dec 31, 202312.0%+21.3
FY2022Dec 31, 2022-9.3%+28.3
FY2021Dec 31, 2021-37.6%+9.2
FY2020Dec 31, 2020-46.8%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 20263.0%+2.1
Q2 FY2026Jun 30, 2026-3.0%+1.1
Q1 FY2026Mar 31, 20268.5%+0.3
Q4 FY2025Dec 31, 2025-1.8%+1.6
Q3 FY2025Sep 30, 20250.9%−14.4
Q2 FY2025Jun 30, 2025-4.2%−27.2
Q1 FY2025Mar 31, 20258.2%−11.6
Q4 FY2024Dec 31, 2024-3.4%−25.6
Q3 FY2024Sep 30, 202415.3%−8.5
Q2 FY2024Jun 30, 202423.1%+28.2
Q1 FY2024Mar 31, 202419.8%+17.8
Q4 FY2023Dec 31, 202322.3%+18.6
Q3 FY2023Sep 30, 202323.8%+24.8
Q2 FY2023Jun 30, 2023-5.2%−6.6
Q1 FY2023Mar 31, 20231.9%+51.6
Q4 FY2022Dec 31, 20223.7%+64.2
Q3 FY2022Sep 30, 2022-1.0%+29.9
Q2 FY2022Jun 30, 20221.5%+24.3
Q1 FY2022Mar 31, 2022-49.6%−12.9
Q4 FY2021Dec 31, 2021-60.5%−42.5
Q3 FY2021Sep 30, 2021-30.9%−12.7
Q2 FY2021Jun 30, 2021-22.8%+75.8
Q1 FY2021Mar 31, 2021-36.7%+16.8
Q4 FY2020Dec 31, 2020-18.0%–
Q3 FY2020Sep 30, 2020-18.2%–
Q2 FY2020Jun 30, 2020-98.7%–
Q1 FY2020Mar 31, 2020-53.6%–

More Vireo Growth figures

See a number that looks wrong?